Cumberland Pharmaceuticals (CPIX) Income from Non-Controlling Interests (2010 - 2026)
Cumberland Pharmaceuticals' Income from Non-Controlling Interests came in at $1,947 for Q2 2026, down 64.8% from $5,533 a year earlier and down 24.8% from the prior quarter.
Powered by 
Analysis
Cumberland Pharmaceuticals (CPIX) Income from Non-Controlling Interests (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Cumberland Pharmaceuticals reported Income from Non-Controlling Interests of -$20,697; for FY2025, it came in at -$28,583.
- Going back by year, Income from Non-Controlling Interests was $36,055 in FY2024, -$51,446 in FY2023, -$79,798 in FY2022 and -$95,212 in FY2021.
- The five-year range for quarterly Income from Non-Controlling Interests is -$36,561 (Q4 2021) to $43,791 (Q1 2024).
- Business Quant data shows CPIX's Income from Non-Controlling Interests at $2,588 (Q1 2026), -$16,950 (Q4 2025) and -$8,282 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.00 Mn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -2.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -7.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 1.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 10.00 Mn |
| 10 | Cumberland Pharmaceuticals | 110.73 Mn | 68.88 Mn | - | 1,947.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1,947.00 |
| Mar 31, 2026 | 2,588.00 |
| Dec 31, 2025 | -16,950.00 |
| Sep 30, 2025 | -8,282.00 |
| Jun 30, 2025 | 5,533.00 |
| Mar 31, 2025 | -8,884.00 |
| Dec 31, 2024 | 2,177.00 |
| Sep 30, 2024 | 7,112.00 |
| Jun 30, 2024 | -17,025.00 |
| Mar 31, 2024 | 43,791.00 |
| Dec 31, 2023 | -7,581.00 |
| Sep 30, 2023 | -13,921.00 |
| Jun 30, 2023 | -10,046.00 |
| Mar 31, 2023 | -19,898.00 |
| Dec 31, 2022 | -18,985.00 |
| Sep 30, 2022 | -14,587.00 |
| Jun 30, 2022 | -29,046.00 |
| Mar 31, 2022 | -17,180.00 |
| Dec 31, 2021 | -36,561.00 |
| Sep 30, 2021 | -31,415.00 |
API Access
Cumberland Pharmaceuticals Income from Non-Controlling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=CPIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "CPIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=CPIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();